Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288699 · ClinicalTrials.gov registry record · NA
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
A NA study of Anxiety and Alcohol Abuse, sponsored by Michael J. Zvolensky, Ph.D..
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05288699: Recruiting NA study of Anxiety and Alcohol Abuse, sponsored by Michael J. Zvolensky, Ph.D..
NCT05288699 is a NA study of Anxiety and Alcohol Abuse that is actively recruiting participants, run by Michael J. Zvolensky, Ph.D.. The registered enrollment target is 50 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05288699, a NA study of Anxiety and Alcohol Abuse, is actively recruiting participants, sponsored by Michael J. Zvolensky, Ph.D..
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Latinx hazardous drinkers with clinical anxiety.
Conditions Studied
Interventions
- BEHAVIORAL Aliento
Study Locations (1)
Texas
- RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-11-04 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What NCT05288699 shows while recruiting
NCT05288699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Aliento is the first listed.
NCT05288699 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05288699 about?
NCT05288699 is a clinical study titled "Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety". The purpose of this study is to develop and examine a culturally adapted, brief, integrated, Spanish language mobile health application for the Android platform, optimized to deliver a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelat...
What is the current status of trial NCT05288699?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-11-04. Estimated completion is 2025-04-30.
What conditions does trial NCT05288699 study?
This clinical trial studies the following conditions: Anxiety, Alcohol Abuse.
What interventions are being tested in trial NCT05288699?
The interventions under investigation include: Aliento (BEHAVIORAL).
Who is sponsoring clinical trial NCT05288699?
This trial is sponsored by Michael J. Zvolensky, Ph.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05288699 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05288699's enrollment target sits among peer trials
50 246th of 364 higher than 110 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI